Home > Resources > Company Profiles > Pfizer, Incorporated

Pfizer, Incorporated (PFE)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Enter the text you see in the image *

Letters are not case-sensitive, disregard spaces.

Try a New One

This helps us prevent automated registrations and spamming.

Email Confirmation

Jeffrey B. Kindler , CEO/Chairman of the Board/Director

www.pfizer.com

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

A research-based, global pharmaceutical company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

Portfolio Articles

Cost Cuts and Dollar Lift Pfizer
Drug maker increases its 2008 outlook.
Jan 23 2008
The Wild Blue Yonder of Markets
Two authors tout "virtuous investing," but shareholders should note the red flags.
Dec 17 2007
Pfizer Profit Plummets
Company says it has halted production of Exubera.
Oct 18 2007
The S.E.C. Inspector Calls
Securities regulator asks 300 companies to explain how they set executive pay.
Aug 31 2007
Pfizers Big Profit Drop

A sharp decline in sales of Lipitor hurts earnings at world's biggest drug company.

Jul 18 2007

See more news on this company

News Feeds

International sales lift Pfizer 2Q profit AP
Jul 23 2008
Earnings roundup: Pfizer, General Dynamics AP
Jul 23 2008
Top drug companies' earnings beat forecasts Reuters
Jul 23 2008
Ahead of the Bell: Pfizer rises on earnings AP
Jul 23 2008
Pfizer profit doubles, but anti-smoking drug lags Reuters
Jul 23 2008
Pfizer profit doubles, but anti-smoking drug sags Reuters
Jul 23 2008
Earnings Preview: Big challenges for Pfizer AP
Jul 22 2008
Women on antidepressants may benefit from Viagra AP
Jul 22 2008
Sector Snap: Major pharma declines AP
Jul 18 2008
Genentech ends studies on drug combo safety issue AP
Jul 14 2008

Portfolio Blogs

Silly Counterfeiting Statistics, Bloomberg Edition
Jun 11 2008
Lifting the Curtain on Corporate Contributions
Nov 16 2007
Pfizer Finds a New Way to Sell to Doctors
Oct 15 2007

Pfizer: Well, SEC, Do You Want Better or More?
Oct 15 2007
Comparing Members of the $170 Billion Club
Jun 25 2007

Press Releases

Pfizer Reports Second-Quarter 2008 Results Jul-23-2008, 07:00AM EDT
Seven Summits Research Releases Alerts on MS, PFE, MA, JAVA, and ALL Jul-17-2008, 09:31AM EDT
Pfizer to Showcase Alzheimer's Research and Pipeline at Upcoming Alzheimer's Disease Medical Meeting Jul-14-2008, 01:00PM EDT
Assess the Impact of Patent Expiry for Lipitor on the Commercial Outlook of Pfizer Over 2006-12 with the 'Pfizer Inc: Pharmavitae Profile' Jul-10-2008, 01:02PM EDT
Enlight Biosciences Launched in Collaboration with Merck & Co., Inc., Pfizer, and Eli Lilly Jul-10-2008, 07:30AM EDT

News From Around the Web

News

Pfizer's Q2 Income More Than Doubles (RedOrbit)

Jul 24 2008
Will Pfizer Pfizzle? (Motley Fool)

Jul 24 2008
Joint deal for incubator site (MLive.com)

Jul 24 2008
Loans from the state for ex-employees of Pfizer (CBS 3 Kalamazoo / Battle Creek (WWMT))

Jul 24 2008
Is Pfizer's Viagra Suffering with the Economy? (SeekingAlpha)

Jul 24 2008
Pharmaceutical giants defy downturn (Business Day, South Africa)

Jul 24 2008
Widow Sues Pfizer Over Chantix After Husband's Suicide (Wall Street Journal Health Blog)

Jul 24 2008
Pfizer reports jump in profits (CBS 3 Kalamazoo / Battle Creek (WWMT))

Jul 23 2008
Stocks advance following sharp drop in oil prices ... (WallSt.net)

Jul 23 2008
International sales lift Pfizer 2Q profit (San Jose Mercury News)

Jul 23 2008

Blogs

Senator Targets Merck Over Outsourcing (Pharmalot)

Jul 24 2008
Lilly, Pfizer & The Economies of ED (CNBC: Pharmas Market with Mike Huckman)

Jul 24 2008
Viagra for women: striking a blow for feminism? (Opinion L.A.)

Jul 23 2008
Pfizer reports second-quarter net income more than doubled; Wyeth posts 6.4% fall in net income (FinFacts Ireland)

Jul 23 2008
Is Pfizer's Viagra "Sagging" With The Economy? (CNBC: Pharmas Market with Mike Huckman)

Jul 23 2008

Employees

Number of Employees: 86,600

Revenue per Employee: $496,051

Top Executives

Margaret M. Foran, Divisional Senior VP/Secretary/Other Corporate Officer

Martin Mackay, President, Divisional/Senior VP

Natale S. Ricciardi, Divisional President/Senior VP

William C. Steere, Jr., Director/Other Corporate Officer

Allen P. Waxman, General Counsel/Senior VP

Loretta V. Cangialosi, Vice President/Controller

Frank A. D'Amelio, CFO

Dr.Corey S. Goodman, Ph.D., President, Divisional/Senior VP

M. Anthony Burns, Director/Other Corporate Officer

Ian C. Read, President, Divisional/Senior VP

Dr. Joseph M. Feczko, Chief Medical Officer/Senior VP

Sally Susman, Senior VP/Other Executive Officer

Mary S. McLeod, Senior VP, Divisional

Richard H. Bagger, Senior VP, Divisional

Board of Directors

Constance J. Horner, Director

Margaret M. Foran, Divisional Senior VP/Secretary/Other Corporate Officer

William H. Gray, III, Director

Dr. Dennis A. Ausiello, M.D., Director

William C. Steere, Jr., Director/Other Corporate Officer

Dr. Dana G. Mead, Director

Suzanne Nora Johnson, Director

M. Anthony Burns, Director/Other Corporate Officer

Robert N. Burt, Director

Dr.Michael S. Brown, M.D., Director

W. Don Cornwell, Director

George A. Lorch, Director

William R. Howell, Director

James M. Kilts, Director

Financials

Quarterly

Annual

Income Statement	04/2008	01/2008	10/2007	07/2007
Sales	2.76 Bil.	3.38 Bil.	4.02 Bil.	1.45 Bil.
Gross Operating Profit	9.08 Bil.	9.68 Bil.	7.97 Bil.	9.63 Bil.
Operating Income before D & A (EBITDA)	3.8 Bil.	2.77 Bil.	2.2 Bil.	3.62 Bil.
Total Income Before Interest Expenses (EBIT)	3.56 Bil.	3.16 Bil.	636 Mil.	1.62 Bil.
Total Net Income	2.78 Bil.	2.88 Bil.	761 Mil.	1.27 Bil.
Basic EPS, Total	0.41	0.42	0.11	0.18
Diluted EPS, Total	0.41	0.42	0.11	0.18

BALANCE STATEMENT	04/2008	01/2008	10/2007	07/2007
Cash and Equivalents	NA	NA	2.61 Bil.	2.14 Bil.
Total Assets	NA	NA	41.84 Bil.	41.62 Bil.
Total Liabilities	NA	NA	14.33 Bil.	15.14 Bil.
Total Capitalization	NA	NA	72.65 Bil.	73.87 Bil.

Cash Flow	04/2008	01/2008	10/2007	07/2007
Net Cash From Continuing Operations	NA	NA	9.45 Bil.	4.87 Bil.
Net Cash From Investing Activities	NA	NA	3.59 Bil.	3.55 Bil.
Net Cash From Financing Activities	NA	NA	-12.41 Bil.	-8.16 Bil.
Net Change in Cash & Cash Equivalents	NA	NA	784 Mil.	311 Mil.

Income Statement	2008	2007	2006	2005
Sales	14.37 Bil.	5.61 Bil.	6.36 Bil.	5.81 Bil.
Gross Operating Profit	34.25 Bil.	42.76 Bil.	44.94 Bil.	46.7 Bil.
Operating Income before D & A (EBITDA)	10.53 Bil.	19.58 Bil.	20.5 Bil.	22.12 Bil.
Total Income Before Interest Expenses (EBIT)	9.47 Bil.	13.52 Bil.	12 Bil.	14.35 Bil.
Total Net Income	7.68 Bil.	19.34 Bil.	8.08 Bil.	11.36 Bil.
Basic EPS, Total	1.2	2.67	1.1	1.51
Diluted EPS, Total	1.2	2.66	1.09	1.49

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	NA	1.83 Bil.	2.25 Bil.	1.81 Bil.
Total Assets	NA	46.95 Bil.	41.9 Bil.	39.69 Bil.
Total Liabilities	NA	21.39 Bil.	28.45 Bil.	26.46 Bil.
Total Capitalization	NA	76.9 Bil.	71.97 Bil.	75.56 Bil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	NA	27.84 Bil.	14.73 Bil.	16.34 Bil.
Net Cash From Investing Activities	NA	5.1 Bil.	-5.07 Bil.	-9.42 Bil.
Net Cash From Financing Activities	NA	-23.1 Bil.	-9.22 Bil.	-6.63 Bil.
Net Change in Cash & Cash Equivalents	NA	-420 Mil.	439 Mil.	288 Mil.

Pfizer, Incorporated (PFE)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request